Oncogenic B-RAF V600E signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion

Journal of Investigative Dermatology

Volumn 133, Issue 5, 2013, Pages 1269-1277

  Boyd, Suzanah C ^a   Mijatov, Branka ^a   Pupo, Gulietta M ^a   Tran, Sieu L ^a   Gowrishankar, Kavitha ^a   Shaw, Heather M ^b   Goding, Colin R ^b   Scolyer, Richard A ^c   Mann, Graham J ^a,c   Kefford, Richard F ^a,c   Rizos, Helen ^a   Becker, Therese M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MELANOMA INSTITUTE AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CELL ADHESION MOLECULE; T BOX 3 TRANSCRIPTIONAL REPRESSOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER INVASION; CELL INVASION; CELL MOTILITY; EMBRYO; EMBRYONAL TISSUE; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MELANOCYTE; MELANOMA CELL INVASION; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84876525324     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.421     Document Type: Article

References (41)

1. Balch CM, Soong SJ, Gershenwald JE et al. (2001) Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622-34
2. Bamshad M, Lin RC, Law DJ et al. (1997) Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat Genet 16:311-5
3. Basolo F, Torregrossa L, Giannini R et al. (2010) Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases. J Clin Endocrinol Metab 95:4197-205
4. Becker TM, Philipsz S, Scurr LL et al. (2010) Oncogenic B-RAF(V600E) promotes anchorage-independent survival of human melanocytes. J Invest Dermatol 130:2144-7
5. Bolos V, Peinado H, Perez-Moreno MA et al. (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesench-ymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116:499-511
6. Broekaert SM, Roy R, Okamoto I et al. (2010) Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res 23:763-70
7. Brummelkamp TR, Kortlever RM, Lingbeek M et al. (2002) TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence. J Biol Chem 277:6567-72
8. Brummer T, Martin P, Herzog S et al. (2006) Functional analysis of the regulatory requirements of B-Raf and the B-Raf(V600E) oncoprotein. Oncogene 25:6262-76
9. Cano A, Perez-Moreno MA, Rodrigo I et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2:76-83
10. Conacci-Sorrell M, Simcha I, Ben-Yedidia T et al. (2003) Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 163:847-57
11. Falchook GS, Long GV, Kurzrock R et al. (2012) Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial. Lancet 379:1893-901
12. Flaherty KT, Puzanov I, Kim KB et al. (2010) Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 363:809-19
13. Haass NK, Smalley KS, Li L et al. (2005) Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res 18:150-9
14. Haferkamp S, Tran SL, Becker TM et al. (2009) The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence. Aging 1:542-56
15. Hajra KM, Chen DY, Fearon ER (2002) The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 62:1613-8
16. Hoek K, Rimm DL, Williams KR et al. (2004) Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64:5270-82
17. Hoogaars WM, Barnett P, Rodriguez M et al. (2008) TBX3 and its splice variant TBX3+exon 2a are functionally similar. Pigment Cell Melanoma Res 21:379-87
18. Hsu MY, Meier FE, Nesbit M et al. (2000) E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 156:1515-25
19. Ikoma N, Yamazaki H, Abe Y et al. (2005) S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model. Oncol Rep 14:633-7
20. Johansson P, Pavey S, Hayward N (2007) Confirmation of a BRAF mutation-associated gene expression signature in melanoma. Pigment Cell Res 20:216-21
21. Knauf JA, Sartor MA, Medvedovic M et al. (2011) Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFbeta signaling. Oncogene 30:3153-62
22. Kreizenbeck GM, Berger AJ, Subtil A et al. (2008) Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 17:949-58
23. Kuphal S, Bosserhoff AK (2011) E-cadherin cell-cell communication in melanogenesis and during development of malignant melanoma. Arch Biochem Biophys 524:43-7
24. Lee HS, Cho HH, Kim HK et al. (2007) Tbx3, a transcriptional factor, involves in proliferation and osteogenic differentiation of human adipose stromal cells. Mol Cell Biochem 296:129-36
25. Lin K, Baritaki S, Militello L et al. (2010) The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-kappaB/Snail/RKIP/PTEN circuit. Genes Cancer 1:409-20
26. Lu J, Li XP, Dong Q et al. (2010) TBX2 and TBX3: the special value for anticancer drug targets. Biochim Biophys Acta 1806:268-74
27. Minoo P, Moyer MP, Jass JR (2007) Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. J Pathol 212:124-33
28. Mowla S, Pinnock R, Leaner VD et al. (2010) TPA-induced upregulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration. Biochem J 433:145-53
29. Nucera C, Porrello A, Antonello ZA et al. (2010) B-Raf(V600E) and thrombos-pondin-1 promote thyroid cancer progression. Proc Natl Acad Sci USA 107:10649-54
30. Peres J, Davis E, Mowla S et al. (2010) The highly homologous T-Box transcription factors, TBX2 and TBX3, have distinct roles in the oncogenic process. Genes Cancer 1:272-82
31. Platz A, Egyhazi S, Ringborg U et al. (2008) Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site. Mol Oncol 1:395-405
32. Poser I, Dominguez D, de Herreros AG et al. (2001) Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J Biol Chem 276:24661-6
33. Riesco-Eizaguirre G, Rodriguez I, De la Vieja A et al. (2009) The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res 69:8317-25
34. Rodriguez M, Aladowicz E, Lanfrancone L et al. (2008) Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. Cancer Res 68:7872-81
35. Rowley M, Grothey E, Couch FJ (2004) The role of Tbx2 and Tbx3 in mammary development and tumorigenesis. J Mammary Gland Biol Neoplasia 9:109-18
36. Scurr LL, Pupo GM, Becker TM et al. (2010) IGFBP7 is not required for B-RAF-induced melanocyte senescence. Cell 141:717-27
37. Suzuki A, Sekiya S, Buscher D et al. (2008) Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression. Development 135:1589-95
38. Tsai CN, Tsai CL, Tse KP et al. (2002) The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA 99:10084-9
39. Tsutsumida A, Hamada J, Tada M et al. (2004) Epigenetic silencing of E-and P-cadherin gene expression in human melanoma cell lines. Int J Oncol 25:1415-21
40. Tucci MG, Lucarini G, Brancorsini D et al. (2007) Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma. Br J Dermatol 157:1212-6
41. Viros A, Fridlyand J, Bauer J et al. (2008) Improving melanoma classification by integrating genetic and morphologic features. PLoS Med 5:e120